Senseonics Market Capitalization from 2010 to 2025
| SENS Stock | USD 0.71 0.01 0.93% |
Check Senseonics Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Senseonics Holdings' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Selling General Administrative of 21.1 M or Total Revenue of 11.6 M, as well as many indicators such as Price To Sales Ratio of 15.8, Dividend Yield of 0.0 or PTB Ratio of 4.82. Senseonics financial statements analysis is a perfect complement when working with Senseonics Holdings Valuation or Volatility modules.
Senseonics | Market Capitalization |
Latest Senseonics Holdings' Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Senseonics Holdings over the last few years. It is Senseonics Holdings' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Senseonics Holdings' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 469.33 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Senseonics Market Capitalization Regression Statistics
| Arithmetic Mean | 257,746,109 | |
| Geometric Mean | 74,744,308 | |
| Coefficient Of Variation | 108.55 | |
| Mean Deviation | 179,498,865 | |
| Median | 259,328,126 | |
| Standard Deviation | 279,771,269 | |
| Sample Variance | 78272T | |
| Range | 1.1B | |
| R-Value | 0.57 | |
| Mean Square Error | 56756.9T | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 33,408,460 | |
| Total Sum of Squares | 1174079.4T |
Senseonics Market Capitalization History
About Senseonics Holdings Financial Statements
Senseonics Holdings shareholders use historical fundamental indicators, such as Market Capitalization, to determine how well the company is positioned to perform in the future. Although Senseonics Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in Senseonics Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on Senseonics Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring systems for people with diabetes in the United States, Europe, the Middle East, and Africa. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. Senseonics Holdings operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 89 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Senseonics Stock Analysis
When running Senseonics Holdings' price analysis, check to measure Senseonics Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senseonics Holdings is operating at the current time. Most of Senseonics Holdings' value examination focuses on studying past and present price action to predict the probability of Senseonics Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senseonics Holdings' price. Additionally, you may evaluate how the addition of Senseonics Holdings to your portfolios can decrease your overall portfolio volatility.